Apyx Medical Corp 10-Q filing
Filed 2026-05-07 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001437749-26-015652
- Form type
- 10-Q
- CIK
- 0000719135
- Primary document
- https://www.sec.gov/Archives/edgar/data/719135/000143774926015652/apyx20260331_10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Apyx Medical Corp.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $12.5M | - | - |
| Cost Of Revenue | $4.6M | - | - |
| Gross Profit | $7.9M | - | - |
| Operating Income | $-911,000 | - | - |
| Net Income | $-2.1M | - | - |
| Eps Basic | -0.05 | - | - |
| Cash And Equivalents | $31.1M | - | - |
| Total Assets | $63.0M | - | - |
| Total Liabilities | $49.9M | - | - |
| Shareholders Equity | $12.8M | - | - |
| Operating Cash Flow | $-572,000 | - | - |
| Capital Expenditures | $60,000 | - | - |